Cargando…
Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver
OBJECTIVE: Gremlin 1 (GREM1) is a secreted BMP2/4 inhibitor which regulates commitment and differentiation of human adipose precursor cells and prevents the browning effect of BMP4. GREM1 is an insulin antagonist and serum levels are high in type 2 diabetes (T2D). We here examined in vivo effects of...
Autores principales: | Khatib Shahidi, Roxana, M. Hoffmann, Jenny, Hedjazifar, Shahram, Bonnet, Laurianne, K. Baboota, Ritesh, Heasman, Stephanie, Church, Christopher, Elias, Ivet, Bosch, Fatima, Boucher, Jeremie, Hammarstedt, Ann, Smith, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895349/ https://www.ncbi.nlm.nih.gov/pubmed/33606810 http://dx.doi.org/10.1371/journal.pone.0247300 |
Ejemplares similares
-
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
por: Baboota, Ritesh K., et al.
Publicado: (2022) -
BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice
por: Hoffmann, Jenny M., et al.
Publicado: (2019) -
Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH
por: Bonnet, Laurianne, et al.
Publicado: (2022) -
Restricted Adipogenesis in Hypertrophic Obesity: The Role of WISP2, WNT, and BMP4
por: Gustafson, Birgit, et al.
Publicado: (2013) -
CCN5/WISP2 and metabolic diseases
por: Grünberg, John R, et al.
Publicado: (2017)